Articles tagged "Outcome"

2022 American Transplant Congress
Lung Transplantation For Covid-19: An International Registry
M. G. Ison¹, R. Giris², O. Dias³, R. Vos⁴, J. Magnusson⁵, T. Zangeneh⁶, E. D. Lease⁷, S. Aslam⁸, M. Weder⁹
¹Northwestern University Comprehensive Transplant Center, Chicago, IL, ²Spectrum Health, Grand Rapids, MI, ³Einstein Hospital, Buenos Aires, Argentina, ⁴UZ Leuven, Leuven, Belgium, ⁵Sahlgrenska Transplant Centre, Stockholm, Sweden, ⁶University of Arizona, Tucscon, AZ, ⁷University of Washington, Seattle, WA, ⁸University of California San Diego, San Diego, CA, ⁹University of Virginia, Charlottesville, VA
*Purpose: SARS-CoV-2 can result in a range of infections from asymptomatic disease to progressive COVID-19 and death. In some patients with COVID-19 Lung Disease (C19LD),…
2022 American Transplant Congress
Outcomes Following Liver Re-Transplantation for Delayed Graft Loss in Recipients of Donation After Circulatory Death Allografts in the United States
S. Kumar¹, S. Lin², J. D. Schold³
¹Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, ²Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, ³Center for Populations Health Research, Cleveland Clinic Foundation, Cleveland, OH
*Purpose: Donation after circulatory death (DCD) liver transplant (LT) recipients have a higher likelihood of delayed graft loss due to Ischemic cholangiopathy (IC). Limited data…
2022 American Transplant Congress
Distinct Phenotypes of Kidney Transplant Recipients Aged 80 Years or Older in the United States by Machine Learning Consensus Clustering
S. A. Mao¹, C. Thongprayoon², M. A. Mao³, C. C. Jadlowiec⁴, N. Leeaphorn⁵, M. Cooper⁶, W. Cheungpasitporn²
¹Transplant Surgery, Mayo Clinic, Jacksonville, FL, ²Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ³Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL, ⁴Transplant Surgery, Mayo Clinic, Phoenix, AZ, ⁵Renal Transplant Program, University of Missouri-Kansas City School of Medicine/Saint Luke's Health System, Kansas City, MO, ⁶MedStar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC
*Purpose: Our study aimed to cluster very elderly kidney transplant recipients aged 80 years and above using an unsupervised machine learning approach.*Methods: We performed consensus…
2022 American Transplant Congress
Kidney Transplantation in Mentally Challenged Patients; a Single Center Experience
J. Yagan¹, T. S. Mahmoud¹, O. Gheith¹, P. Nair¹, T. Alotaibi²
¹Nephrology, Hamed Al-Essa Organ Transplant Center, Kuwait, Kuwait, ²Pathology, Hamed Al-Essa Organ Transplant Center, Kuwait, Kuwait
*Purpose: Kidney transplant is the best choice of treatment for patients with end stage kidney disease. There are medical conditions that may pose an ethical…
2022 American Transplant Congress
Mycophenolate Mofetil-Related Diarrhea and Beta-Glucuronidase Activity Following Kidney Transplantation
G. C. Onyeaghala¹, S. Elmer¹, D. Schladt¹, P. Yang¹, M. Wagner², L. Teigen², M. Al-Kofahi², B. Wu², W. Guan², C. Staley², S. Riad², A. Matas³, R. Remmel², W. Oetting², C. R. Dorr¹, P. Jacobson⁴, A. Israni¹
¹Nephrology, Hennepin Healthcare Research Institute, Minneapolis, MN, ²University of Minnesota, Minneapolis, MN, ³University of Minnesota Medical School, Minneapolis, MN, ⁴Univ of MN, College of Pharmacy, Minneapolis, MN
*Purpose: The treatment of mycophenolate mofetil (MMF)-related diarrhea in kidney transplants recipients often involves dose reductions, which may result in less effective immunosuppression. We hypothesize…
2022 American Transplant Congress
Longitudinal Mortality Risks and Renal Functional Outcomes in Living Kidney Donors
K. Hotta¹, T. Osawa¹, I. Yokota², T. Inao², T. Tanabe¹, N. Iwahara¹, N. Shinohara¹
¹Urology, Hokkaido University Hospital, Sapporo, Japan, ²Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
*Purpose: Previous studies have suggested that living kidney donors do not have a higher risk of death or end-stage kidney disease (ESKD) than the general…
2022 American Transplant Congress
Living Related Kidney Donation for Alport Syndrome Spectrum: Long-Term Outcomes
Y. Caliskan¹, A. B. Dirim², S. Safak², B. Yelken³, A. Velioglu⁴, A. Yildiz⁵, O. A. Oto², N. Guller², H. Yazici², A. Ersoy⁵, A. Turkmen³, K. L. Lentine¹
¹Saint Louis University, Saint Louis, MO, ²Istanbul University, Istanbul, Turkey, ³Koc University Hospital, Istanbul, Turkey, ⁴Marmara University, Istanbul, Turkey, ⁵Uludag University, Bursa, Turkey
*Purpose: Data to guide the evaluation of living related donor (LRD) candidates for kidney transplant recipients with Alport syndrome (AS) spectrum are limited. We examined…
2022 American Transplant Congress
Transplant Coordinator Time Saved (TCTS) Through a Hybrid On Call Team for Deceased Donor Kidney and Pancreas Transplant Organ Offers
K. Ko, C. Gregory, J. Le, A. Lutrick, U. Reddy
Division of Kidney and Pancreas Transplantation, UC Irvine, Orange, CA
*Purpose: The purpose of this analysis was to estimate transplant coordinator time saved (TCTS) through the implementation of a hybrid on call team. Historically, transplant…
2022 American Transplant Congress
Evaluation of Diabetes-Free Life Expectancy Among Living Kidney Donors and Non-Donors with Obesity: A Longitudinal Cohort Study
C. Killian¹, R. Reed¹, M. McLeod¹, P. MacLennan¹, V. Kumar¹, S. Brooks¹, A. Maynor¹, L. Stanford¹, G. Baker¹, C. Schinstock², J. Silkensen³, G. Roll⁴, D. Segev⁵, B. Orandi¹, C. Lewis¹, J. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²Mayo Clinic, Rochester, MN, ³Hennepin County Medical Center, Minneapolis, MN, ⁴UCSF Medical Center, San Francisco, CA, ⁵Johns Hopkins University, Baltimore, MD
*Purpose: The growing end stage kidney disease burden paired with substantial rates of obesity in the United States (US) has prompted increased approval of obese…
2022 American Transplant Congress
The New Heart Allocation Policy Has Increased Listing by Exception
J. R. Golbus¹, Y. Ahn², B. K. Nallamothu¹, M. N. Walsh³, D. Zaun², A. Israni², M. Colvin¹
¹University of Michigan, Ann Arbor, MI, ²Hennepin Healthcare Research Institute, Minneapolis, MN, ³Ascension St. Vincent Heart Center, Carmel, IN
*Purpose: The new heart allocation policy (October 2018) expanded the number of listing statuses and established a national review board for exception requests in an…

« Previous Page
1
…
6
7
8
9
10
…
155
Next Page »